CompaniesAdept Therapeutics

Adept Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

349

By Phase

PHASE1: 3PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1RECRUITING: 1ENROLLING_BY_INVITATION: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
Today
NCT04735471
NCT04911478
Hover over trial bars to see details

Recent Trials

NCT07100873Lead Sponsor
A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
PHASE1Not yet recruiting
25 participants
Started: Aug 15, 2025 · Completed: Mar 30, 2028
NCT06480565Lead Sponsor
A Phase 1/2 Trial of ADI-270 in ccRCC
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Dec 12, 2024 · Completed: Jun 30, 2027
NCT06375993Lead Sponsor
A Phase 1 Study of ADI-001 in Autoimmune Disease
PHASE1Recruiting
180 participants
Started: Nov 10, 2024 · Completed: Dec 31, 2027
NCT04911478Lead Sponsor
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
N/AEnrolling by invitation
50 participants
Started: Feb 14, 2022 · Completed: Aug 31, 2039
NCT04735471Lead Sponsor
A Phase 1 Study of ADI-001 in B Cell Malignancies
PHASE1Terminated
34 participants
Started: Mar 4, 2021 · Completed: Feb 3, 2025